AlloVir, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 30.3 million compared to USD 41.18 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.44 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7549 USD | +1.00% | -0.28% | +11.05% |
13/05 | AlloVir, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
20/03 | North American Morning Briefing : Markets on Hold -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.05% | 8.48Cr | |
+11.91% | 11TCr | |
+11.60% | 10TCr | |
-4.68% | 2.38TCr | |
-0.82% | 2.17TCr | |
-10.12% | 1.81TCr | |
-42.12% | 1.63TCr | |
-17.47% | 1.61TCr | |
+2.77% | 1.38TCr | |
+34.58% | 1.18TCr |
- Stock Market
- Equities
- ALVR Stock
- News AlloVir, Inc.
- AlloVir, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024